Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-25-035882
Filing Date
2025-11-20
Accepted
2025-11-20 17:39:26
Documents
1
Period of Report
2025-11-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3502
  Complete submission text file 0001437749-25-035882.txt   5054
Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Issuer) CIK: 0001069530 (see all company filings)

EIN.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 285 MARGALITA DRIVE SAN RAFAEL CA 94901
Business Address
Barry Richard (Reporting) CIK: 0001562371 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41905 | Film No.: 251504078